The global pharmaceutical contract packaging market is predicted to be valued at US$ 6.1 billion in 2023. Contract packaging services in pharmaceuticals are forecasted to advance at 7.5% CAGR from 2023 to 2033. By the end of the year 2033, the overall market is forecasted to reach a valuation of US$ 11.9 billion.
Pharmaceutical Contract Packaging Market Trends
| Report Attributes or Data Points | Details |
|---|---|
| Global Pharmaceutical Contract Packaging Market Size in 2022 | US$ 5.6 billion |
| Estimated Global Market Share in 2023 | US$ 6.1 billion |
| Forecasted Global Market Size by 2033 | US$ 11.9 billion |
| Projected Global Market Growth Rate from 2023 to 2033 | 7.5% CAGR |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Establishing mutually beneficial relationships with contract packaging organizations (CPOs) to avoid a lack of resources and budgets is driving the pharmaceutical contract packaging market growth. Furthermore, it is anticipated to rise with the implementation of serialization that mandates the barcodes and transfer of data in the supply of medicines.
The rising prevalence of atmosphere-sensitive pharmaceutical drugs has surged the demand for silica-based packaging material as the latest pharmaceutical contract packaging market trend. Moreover, a proliferation of the geriatric population in developed regions highly dependent on pharmaceutical drugs is projected to boost the sales of pharmaceutical contract packaging.
Key Pharmaceutical Contract Packaging Market Dynamics
New treatments such as gene and cell therapies, and growing demand for bio-products are some of the factors driving the adoption of pharmaceutical contract packaging. The capability of vendors to undertake several packaging projects, including sorting issues arising from complex packaging requirements surges the adoption of pharmaceutical contract packaging.
Government execution of new regulations to control the quality of pharmaceutical products available in the market is driving innovations in pharmaceutical product packaging and labeling. Generic pharmaceuticals of lower cost increasing in popularity and requiring efficient packaging and protection during storage and shipping is projected to boost the demand further.
Drawbacks in the Pharmaceutical Contract Packaging
Fluctuating prices of raw materials used for manufacturing pharmaceutical packaging products are some of the factors anticipated to hamper the market growth. Increasing risks associated with the poor quality of the product as well as design could also compromise the credibility of the pharmaceutical packaging market.
The availability of counterfeit medicines containing false or inactive ingredients across the globe significantly hinders the growth opportunity for the pharmaceutical packaging industry. On top of that, the lack of expertise of employees for effective in-house packaging capabilities, and budget constraints further obstruct the outsourcing trends in pharmaceutical packaging.
North America accounts for the leading market share by generating almost one-third of the global demand for effective pharmaceutical packaging solutions through contracts. The total revenue generated by the United States alone was figured out to be around 90% of the total business in North America.
Quality services offered by the CPOs and CDMOs based in the United States propel the demand for pharmaceutical contract packaging services and solutions in the country. The demand for biological therapies, increase in strict protocols, and rise in the geriatric population could also broaden the global pharma contract packaging market size.
Europe holds a 28% revenue in the pharmaceutical contract packaging market share and is the second most dominating market. Germany was figured out to be leading in terms of the production of assets for the establishment of pharmaceutical contract packaging industries. Over the years from 2023 to 2033, the regional market is expected to advance at a rate of 5% per year.
A large presence of major manufacturers operating in the pharmaceutical industry creates lucrative opportunities and increases the adoption of pharmaceutical contract packaging. Increasing the use of plastic bottles and containers, vials & ampoules, and pre-fillable syringes could also boost the demand for pharmaceutical contract packaging in this region.
The Asia Pacific is anticipated to grow at a remarkable CAGR in pharmaceutical contract packaging services and products in the coming days. China is the leading market hear that is poised to exhibit a year-on-year increment of 8.7% from 2023 to 2033.
Increasing demand for biological therapies and rigid protocols associated with packaging processes have created a huge demand for outsourced pharmaceutical packaging in the country. In addition to this, the presence of several pharmaceutical contract packaging service providers in the region has boosted the overall market size in the past.
The sales of pharmaceutical contract packaging are anticipated to rise owing to the rapid outsourcing of pharmaceutical manufacturing to emerging countries, such as India. India, in particular, is anticipated to exhibit a lucrative growth rate of 9.1% over the forecast years.
In the table below we have represented the regional growth rates of different countries in pharmaceutical contract packaging. Though the countries in North America and Europe lead the global business, the emerging economies promise greater opportunities in this industry.
| Regional Market Comparison | CAGR (2023 to 2033) |
|---|---|
| United States | 4.8% |
| Germany | 5% |
| United Kingdom | 6.4% |
| India | 9.1% |
| China | 8.7% |
Principal Consultant
North America accounts for the leading market share by generating almost one-third of the global demand for effective pharmaceutical packaging solutions through contracts. The total revenue generated by the United States alone was figured out to be around 90% of the total business in North America.
Quality services offered by the CPOs and CDMOs based in the United States propel the demand for pharmaceutical contract packaging services and solutions in the country. The demand for biological therapies, increase in strict protocols, and rise in the geriatric population could also broaden the global pharma contract packaging market size.
Europe holds a 28% revenue in the pharmaceutical contract packaging market share and is the second most dominating market. Germany was figured out to be leading in terms of the production of assets for the establishment of pharmaceutical contract packaging industries. Over the years from 2023 to 2033, the regional market is expected to advance at a rate of 5% per year.
A large presence of major manufacturers operating in the pharmaceutical industry creates lucrative opportunities and increases the adoption of pharmaceutical contract packaging. Increasing the use of plastic bottles and containers, vials & ampoules, and pre-fillable syringes could also boost the demand for pharmaceutical contract packaging in this region.
The Asia Pacific is anticipated to grow at a remarkable CAGR in pharmaceutical contract packaging services and products in the coming days. China is the leading market hear that is poised to exhibit a year-on-year increment of 8.7% from 2023 to 2033.
Increasing demand for biological therapies and rigid protocols associated with packaging processes have created a huge demand for outsourced pharmaceutical packaging in the country. In addition to this, the presence of several pharmaceutical contract packaging service providers in the region has boosted the overall market size in the past.
The sales of pharmaceutical contract packaging are anticipated to rise owing to the rapid outsourcing of pharmaceutical manufacturing to emerging countries, such as India. India, in particular, is anticipated to exhibit a lucrative growth rate of 9.1% over the forecast years.
In the table below we have represented the regional growth rates of different countries in pharmaceutical contract packaging. Though the countries in North America and Europe lead the global business, the emerging economies promise greater opportunities in this industry.
| Regional Market Comparison | CAGR (2023 to 2033) |
|---|---|
| United States | 4.8% |
| Germany | 5% |
| United Kingdom | 6.4% |
| India | 9.1% |
| China | 8.7% |
To protect pharmaceutical products better than conventional materials, startups in pharmaceutical contract packaging strive to develop enhanced packaging solutions. This is changing the landscape of pharmaceutical contact packaging and generating newer and more innovative ideas to tackle every challenge.
Hence, some start-up companies such as Veneti, Unipharm Healthy Manufacturing, V-Shapes, Blistr, Calyx Containers, etc. are coming up with various strategies to scale their business. They are mostly resorting to novel solutions like medical cannabis containers, biodegradable pharma packaging, single-portion packets, contract pharmaceutical packaging with labeling and distribution, etc.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Some of the recent developments in pharmaceutical contract packaging are
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 7.5% from 2023 to 2033 |
| The base year for estimation | 2022 |
| Historical data | 2018 to 2022 |
| Forecast period | 2023 to 2033 |
| Quantitative units | Revenue in US$ million or billion and CAGR from 2022 to 2032 |
| Report Coverage | Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis, |
| Segments Covered | By Type, By Form, By Application, and By Region. |
| Regional scope | North America; Western Europe, Eastern Europe, Middle East and Africa (MEA), ASEAN, South Asia, Rest of Asia, Australia, and New Zealand |
| Country scope | United States of America; Canada; Mexico; Germany; United Kingdom; France; Italy; Spain; Russia; Belgium; Poland; Czech Republic; China; India; Japan; Australia; Brazil; Argentina; Colombia; Saudi Arabia; UAE; Iran; South Africa |
| Key companies profiled | Catalent Pharma Solutions, Patheon, Baxter BioPharma Solutions, AbbVie Contract Manufacturing, Pfizer Centre Source, Daito Pharmaceutical, Nipro Corporation, Becton Dickinson & Company, AptarGroup Inc., Drug Plastics Group, Gerresheimer AG, Schott AG, Owens Illinois Inc., WestRock Company SGD S.A., International Paper Company, COMAR LLC, CCL Industries Inc., Vetter Pharma International, Adelphi Healthcare Packaging, Sharp Corporation, Amcor Limited, Berry Plastics Corporation, MeadWestvaco Corporation, Becton Dickinson and Company, Owens-Illinois Inc., West Pharmaceuticals Services Inc., Schott Pharmaceuticals Services Inc., RPC Group Plc, Graphic Packaging International Inc., etc. |
| Customization scope | Free report customization (equivalent to up to 8 analysts' working days) with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. |
The global pharmaceutical contract packaging market value was US$ 5.6 billion in 2022.
The pharmaceutical contract packaging market is likely to follow a 7.5% CAGR through 2033
Catalent, Patheon, Baxter, and AbbVie are the leading market players currently.
The United States accounts for nearly 90% revenue share of the North America market.
India could exhibit a 9.1% CAGR in pharmaceutical contract packaging through 2033.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Type, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Type, 2023 to 2033
5.3.1. Flexible Packaging
5.3.2. Plastic/Glass Containers
5.3.3. Caps/Closures
5.4. Y-o-Y Growth Trend Analysis By Type, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Type, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Form
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Form, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Form, 2023 to 2033
6.3.1. Oral
6.3.2. Injectable
6.4. Y-o-Y Growth Trend Analysis By Form, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Form, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Application, 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Application, 2023 to 2033
7.3.1. Autacoids & Related Drugs
7.3.2. Contraceptives
7.3.3. Hormone Replacement
7.3.4. Cardiovascular Medicines
7.3.5. Cancer Therapies
7.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022
7.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022
8.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033
8.3.1. North America
8.3.2. Latin America
8.3.3. Western Europe
8.3.4. Eastern Europe
8.3.5. South Asia and Pacific
8.3.6. East Asia
8.3.7. Middle East and Africa
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. USA
9.2.1.2. Canada
9.2.2. By Type
9.2.3. By Form
9.2.4. By Application
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Type
9.3.3. By Form
9.3.4. By Application
9.4. Key Takeaways
10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Type
10.2.3. By Form
10.2.4. By Application
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Type
10.3.3. By Form
10.3.4. By Application
10.4. Key Takeaways
11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. UK
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Western Europe
11.2.2. By Type
11.2.3. By Form
11.2.4. By Application
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Type
11.3.3. By Form
11.3.4. By Application
11.4. Key Takeaways
12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. Poland
12.2.1.2. Russia
12.2.1.3. Czech Republic
12.2.1.4. Romania
12.2.1.5. Rest of Eastern Europe
12.2.2. By Type
12.2.3. By Form
12.2.4. By Application
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Type
12.3.3. By Form
12.3.4. By Application
12.4. Key Takeaways
13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Bangladesh
13.2.1.3. Australia
13.2.1.4. New Zealand
13.2.1.5. Rest of South Asia and Pacific
13.2.2. By Type
13.2.3. By Form
13.2.4. By Application
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Type
13.3.3. By Form
13.3.4. By Application
13.4. Key Takeaways
14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. China
14.2.1.2. Japan
14.2.1.3. South Korea
14.2.2. By Type
14.2.3. By Form
14.2.4. By Application
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Type
14.3.3. By Form
14.3.4. By Application
14.4. Key Takeaways
15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. GCC Countries
15.2.1.2. South Africa
15.2.1.3. Israel
15.2.1.4. Rest of MEA
15.2.2. By Type
15.2.3. By Form
15.2.4. By Application
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Type
15.3.3. By Form
15.3.4. By Application
15.4. Key Takeaways
16. Key Countries Market Analysis
16.1. USA
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2022
16.1.2.1. By Type
16.1.2.2. By Form
16.1.2.3. By Application
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2022
16.2.2.1. By Type
16.2.2.2. By Form
16.2.2.3. By Application
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2022
16.3.2.1. By Type
16.3.2.2. By Form
16.3.2.3. By Application
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2022
16.4.2.1. By Type
16.4.2.2. By Form
16.4.2.3. By Application
16.5. Germany
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2022
16.5.2.1. By Type
16.5.2.2. By Form
16.5.2.3. By Application
16.6. UK
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2022
16.6.2.1. By Type
16.6.2.2. By Form
16.6.2.3. By Application
16.7. France
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2022
16.7.2.1. By Type
16.7.2.2. By Form
16.7.2.3. By Application
16.8. Spain
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2022
16.8.2.1. By Type
16.8.2.2. By Form
16.8.2.3. By Application
16.9. Italy
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2022
16.9.2.1. By Type
16.9.2.2. By Form
16.9.2.3. By Application
16.10. Poland
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2022
16.10.2.1. By Type
16.10.2.2. By Form
16.10.2.3. By Application
16.11. Russia
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2022
16.11.2.1. By Type
16.11.2.2. By Form
16.11.2.3. By Application
16.12. Czech Republic
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2022
16.12.2.1. By Type
16.12.2.2. By Form
16.12.2.3. By Application
16.13. Romania
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2022
16.13.2.1. By Type
16.13.2.2. By Form
16.13.2.3. By Application
16.14. India
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2022
16.14.2.1. By Type
16.14.2.2. By Form
16.14.2.3. By Application
16.15. Bangladesh
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2022
16.15.2.1. By Type
16.15.2.2. By Form
16.15.2.3. By Application
16.16. Australia
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2022
16.16.2.1. By Type
16.16.2.2. By Form
16.16.2.3. By Application
16.17. New Zealand
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2022
16.17.2.1. By Type
16.17.2.2. By Form
16.17.2.3. By Application
16.18. China
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2022
16.18.2.1. By Type
16.18.2.2. By Form
16.18.2.3. By Application
16.19. Japan
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2022
16.19.2.1. By Type
16.19.2.2. By Form
16.19.2.3. By Application
16.20. South Korea
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2022
16.20.2.1. By Type
16.20.2.2. By Form
16.20.2.3. By Application
16.21. GCC Countries
16.21.1. Pricing Analysis
16.21.2. Market Share Analysis, 2022
16.21.2.1. By Type
16.21.2.2. By Form
16.21.2.3. By Application
16.22. South Africa
16.22.1. Pricing Analysis
16.22.2. Market Share Analysis, 2022
16.22.2.1. By Type
16.22.2.2. By Form
16.22.2.3. By Application
16.23. Israel
16.23.1. Pricing Analysis
16.23.2. Market Share Analysis, 2022
16.23.2.1. By Type
16.23.2.2. By Form
16.23.2.3. By Application
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Type
17.3.3. By Form
17.3.4. By Application
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Catalent Pharma Solutions
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.1.5.2. Product Strategy
18.1.1.5.3. Channel Strategy
18.1.2. Patheon
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.2.5.2. Product Strategy
18.1.2.5.3. Channel Strategy
18.1.3. Baxter BioPharma Solutions
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.3.5.2. Product Strategy
18.1.3.5.3. Channel Strategy
18.1.4. AbbVie Contract Manufacturing
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.4.5.2. Product Strategy
18.1.4.5.3. Channel Strategy
18.1.5. Pfizer CentreSource
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.5.5.2. Product Strategy
18.1.5.5.3. Channel Strategy
18.1.6. Daito Pharmaceutical
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.6.5.2. Product Strategy
18.1.6.5.3. Channel Strategy
18.1.7. Nipro Corporation
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.7.5.2. Product Strategy
18.1.7.5.3. Channel Strategy
18.1.8. Becton Dickinson & Company
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.8.5.2. Product Strategy
18.1.8.5.3. Channel Strategy
18.1.9. AptarGroup Inc
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.9.5.2. Product Strategy
18.1.9.5.3. Channel Strategy
18.1.10. Drug Plastics Group
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
18.1.10.5.2. Product Strategy
18.1.10.5.3. Channel Strategy
18.1.11. Gerresheimer AG
18.1.11.1. Overview
18.1.11.2. Product Portfolio
18.1.11.3. Profitability by Market Segments
18.1.11.4. Sales Footprint
18.1.11.5. Strategy Overview
18.1.11.5.1. Marketing Strategy
18.1.11.5.2. Product Strategy
18.1.11.5.3. Channel Strategy
19. Assumptions & Acronyms Used
20. Research Methodology
Explore Packaging Insights
View Reports
Pharmaceutical Contract Packaging Market
